Clarify Pharma is an investment vehicle specialising in biotech and life sciences companies seeking to prove the safety and efficacy of psychedelic-based substances. The company believes that the psychedelics sector is likely to undergo a paradigm shift comparable to that experienced by cannabis, which resulted in the emergence of a global industry worth billions.
We helped raise £3 million of pre-IPO funding for Clarify before ultimately managing their IPO on the Aquis Exchange and acting as corporate adviser and joint broker. This listing helped raise the company a further £2 million.
Visit the website